These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 29954633)
1. A comparison of different surfactants on foam stability in foam sclerotherapy in vitro. Bai T; Liu Y; Liu J; Yu C; Jiang W; Fan Y J Vasc Surg; 2019 Feb; 69(2):581-591.e1. PubMed ID: 29954633 [TBL] [Abstract][Full Text] [Related]
2. Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy. Bai T; Jiang W; Chen Y; Yan F; Xu Z; Fan Y Sci Rep; 2018 Oct; 8(1):15683. PubMed ID: 30356108 [TBL] [Abstract][Full Text] [Related]
3. Properties of polidocanol foam in view of its use in sclerotherapy. Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198 [TBL] [Abstract][Full Text] [Related]
4. Studies on Foam Decay Trend and Influence of Temperature Jump on Foam Stability in Sclerotherapy. Bai T; Chen Y; Jiang W; Yan F; Fan Y Vasc Endovascular Surg; 2018 Feb; 52(2):98-106. PubMed ID: 29173136 [TBL] [Abstract][Full Text] [Related]
5. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins. Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112 [TBL] [Abstract][Full Text] [Related]
6. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations. Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463 [TBL] [Abstract][Full Text] [Related]
7. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability. Chen AW; Liu YR; Li K; Liu SH Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207 [TBL] [Abstract][Full Text] [Related]
8. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Rao J; Goldman MP Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090 [TBL] [Abstract][Full Text] [Related]
9. Polidocanol foam stability in terms of its association with glycerin. Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491 [TBL] [Abstract][Full Text] [Related]
10. Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment. Bai T; Jiang W; Fan Y Dermatol Surg; 2018 May; 44(5):689-696. PubMed ID: 29140865 [TBL] [Abstract][Full Text] [Related]
11. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams. Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Pushing Rate on Foam Stability in the Tessari Method. Azmoun S; Liu Y; Bian K; Chen A; Liu S Dermatol Surg; 2024 Jun; 50(6):542-545. PubMed ID: 38460194 [TBL] [Abstract][Full Text] [Related]
13. A new method for using radiopaque sclerosing foam to treat venous malformations. Li K; Liu YR; Chen AW; Liu SH Dermatol Surg; 2015 Jun; 41(6):726-30. PubMed ID: 25973562 [TBL] [Abstract][Full Text] [Related]
14. An Optical Method for Immediate Evaluation of Microfoam Stability in Foam Sclerotherapy. Bai T; Jiang W; Liang L; Li Y; Fan Y Skin Pharmacol Physiol; 2021; 34(3):128-134. PubMed ID: 33794544 [TBL] [Abstract][Full Text] [Related]
15. Foam sclerosants are more stable at lower temperatures. Valenzuela GC; Wong K; Connor DE; Behnia M; Parsi K Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):593-9. PubMed ID: 24070851 [TBL] [Abstract][Full Text] [Related]
16. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model. McAree B; Ikponmwosa A; Brockbank K; Abbott C; Homer-Vanniasinkam S; Gough MJ Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):721-5. PubMed ID: 22507925 [TBL] [Abstract][Full Text] [Related]
17. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins. Star P; Connor DE; Parsi K Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694 [TBL] [Abstract][Full Text] [Related]
18. Improvement of stability of polidocanol foam for nonsurgical permanent contraception. Guo JX; Lucchesi L; Gregory KW Contraception; 2015 Aug; 92(2):103-7. PubMed ID: 26070858 [TBL] [Abstract][Full Text] [Related]
19. Effects of sulodexide on stability of sclerosing foams. Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533 [TBL] [Abstract][Full Text] [Related]
20. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy? Lai SW; Goldman MP J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]